Prostate Cancer Health Center
Cryotherapy for Prostate Cancer Treatment
Cryotherapy uses extreme icy temperatures to freeze and destroy cancer tissue and cells in the prostate. There are few long-term studies that focus on cryotherapy as a treatment for prostate cancer.
The prostate gland surrounds the bottom of a man's bladder and about the first inch of the urinary tube, or urethra. It has a key role in male reproduction. The prostate gland secretes seminal fluid. That fluid combines with sperm to make semen.
As a man ages, the prostate often becomes the target of several problems. One of these is prostate cancer. Each year, more than 200,000 men are diagnosed with prostate cancer. It is the most commonly diagnosed cancer in American men after non-melanoma skin cancer.
Even with early intervention and conventional treatment, 30% to 40% of men experience a recurrence of prostate cancer. That means they will need further treatment. Some experts think cryotherapy is an option for treating recurrent prostate cancer.
How is cryotherapy done?
With cryotherapy, an ultra-thin metal probe or needle is inserted into the prostate gland. This is done through an incision that lies between the anus and scrotum. To protect the urethra from the procedure's icy temperatures, a warm saline solution flows through a catheter.
The surgeon uses visual information produced by ultrasound as a guide during the process. A freezing liquid, such as liquid nitrogen or argon gas, is infused through the probe into the prostate gland. The intense cold freezes the prostate and destroys any cancerous tissue it contains. Using the images from the ultrasound to identify the cancer tissue, the surgeon can limit damage to normal prostate tissue.
How does cryotherapy destroy prostate cancer?
Any living tissue -- healthy or unhealthy -- cannot tolerate extreme cold. Infusing nitrogen or argon gas into the prostate gland rapidly extracts heat from the gland. As heat is drawn out, there is an instantaneous swell of ice crystals or ice balls. This results in the rupture of cell membranes. That's followed by tissue damage and, ultimately, cell death.
After the cancer cells are destroyed, white blood cells clean up the dead cells and tissue. Some studies show that during this process, the immune system strikes out and attacks cancer cells that still remain.
WebMD Medical Reference
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.

